Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

Neuro-Oncology
Daniel Honore Lachance, M.D.
"Understanding the Genetic Risk of IDH Mutant Glioma"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Define the background for current understanding of lower grade glioma and relevance of IDH mutation
• Summarize the significance of germline genetic risk for IDH mutant glioma
• Illustrate recent discovery of potential mechanism of the dominant 8q24 germline risk variant for IDH mutant glioma

Dr. Lachance does not have any relevant financial relationships to disclose and does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.